Related Experiment Video

Updated: Jul 20, 2026

Exploring the Pharmacological Action and Molecular Mechanism of Salidroside in Inhibiting MCF-7 Cell Proliferation and Migration
11:13

Exploring the Pharmacological Action and Molecular Mechanism of Salidroside in Inhibiting MCF-7 Cell Proliferation and Migration

Published on: June 9, 2023

[siRNA-cyclin D1 inhibit cell proliferation in breast cancer MCF-7 cell line]

Lei Jiang1, Ri Shu Chen, Ji Cheng Li

  • 1Institute of Cell Biology, Zhejiang University, Hangzhou.

Fen Zi Xi Bao Sheng Wu Xue Bao = Journal of Molecular Cell Biology
|September 2, 2006
PubMed

Insights

Small interfering RNA (siRNA) targeting cyclin D1 effectively inhibited breast cancer cell proliferation. This approach offers a promising gene therapy strategy for breast cancer treatment.

Area of Science:

  • Molecular Biology
  • Cancer Research
  • Gene Therapy

Context:

  • Breast cancer remains a leading cause of mortality worldwide, necessitating novel therapeutic strategies.
  • Cyclin D1 is a key regulator of cell cycle progression, often overexpressed in various cancers, including breast cancer.
  • RNA interference (RNAi) using small interfering RNA (siRNA) presents a targeted approach to gene silencing.

Purpose:

  • To investigate the efficacy of siRNA targeting cyclin D1 in suppressing its expression in the MCF-7 breast cancer cell line.
  • To evaluate the impact of cyclin D1 knockdown on MCF-7 cell proliferation, cell cycle progression, and colony formation.
  • To assess the potential of siRNA-cyclin D1 as an anti-proliferative therapeutic agent for breast cancer gene therapy.

Summary:

  • Chemically synthesized siRNA targeting cyclin D1 was transfected into MCF-7 cells.
  • Quantitative PCR and Western blot analysis confirmed significant dose-dependent suppression of cyclin D1 mRNA and protein expression.
  • CCK-8 assays, flow cytometry, and soft-agar colony formation assays demonstrated that siRNA-cyclin D1 inhibited cell proliferation, induced G1 phase arrest, and reduced colony-forming ability.

Impact:

  • The study demonstrates that siRNA-mediated silencing of cyclin D1 effectively inhibits breast cancer cell growth and proliferation.
  • These findings support the potential of siRNA-cyclin D1 as a targeted gene therapy approach for breast cancer.
  • Further research could explore the in vivo efficacy and safety of this therapeutic strategy.

More Related Videos

Analysis of Combinatorial miRNA Treatments to Regulate Cell Cycle and Angiogenesis11:44

Analysis of Combinatorial miRNA Treatments to Regulate Cell Cycle and Angiogenesis

Published on: March 30, 2019

Utilizing Functional Genomics Screening to Identify Potentially Novel Drug Targets in Cancer Cell Spheroid Cultures07:48

Utilizing Functional Genomics Screening to Identify Potentially Novel Drug Targets in Cancer Cell Spheroid Cultures

Published on: December 26, 2016

Related Concept Videos

Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
Inhibition of CDK Activity02:34

Inhibition of CDK Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
Negative Regulator Molecules01:23

Negative Regulator Molecules

Positive regulators allow a cell to advance through cell cycle checkpoints. Negative regulators have an equally important role as they terminate a cell’s progression through the cell cycle—or pause it—until the cell meets specific criteria.
Molecular Factors Affecting Cell Division01:27

Molecular Factors Affecting Cell Division

Several external and internal factors influence the initiation and inhibition of cell division. For instance, the death of nearby cells or the release of human growth hormone (hGH) promotes cell division. In contrast, lack of hGH or crowding of cells can inhibit cell division.
Several proteins function as internal regulators to ensure each cell cycle stage is completed faithfully before proceeding to the next. Regulator molecules may act directly or influence the activity or production of other...
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
Positive Regulator Molecules02:39

Positive Regulator Molecules

Mitotic cell division results in daughter cells that exactly resemble the parent cell. However, errors in the DNA replication or distribution of genetic material may lead to genetic mutations that may be passed down to every new cell formed from the resulting abnormal cell. Propagation of such mutant cells is restricted through checkpoint mechanisms present at different stages of the cell cycle. These checkpoints involve regulator molecules that either promote or demote cell cycle events.